Black Diamond Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 10.47 M | $22.40 M | -2.49% | 18.52% |
| BELLEVUE GROUP AG | 02/14/2025 | 8.52 M | $18.23 M | 0.00% | 15.07% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 5.60 M | $11.98 M | 11.37% | 9.91% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 4.45 M | $9.52 M | 0.00% | 7.87% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.52 M | $7.53 M | 0.61% | 6.23% |
| VANGUARD GROUP INC | 02/11/2025 | 2.41 M | $5.17 M | 4.14% | 4.27% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.07 M | $4.43 M | 51.09% | 3.66% |
| SIREN, L.L.C. | 02/14/2025 | 1.05 M | $2.24 M | 0.00% | 1.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 959,316 | $2.05 M | 1.53% | 1.70% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 904,000 | $1.93 M | 256.19% | 1.60% |
| STATE STREET CORP | 02/14/2025 | 883,441 | $1.89 M | 9.18% | 1.56% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 661,436 | $1.42 M | 158.52% | 1.17% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 559,163 | $1.20 M | 100.00% | 0.99% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 558,076 | $1.19 M | 146.12% | 0.99% |
| 02/14/2025 | 506,000 | $1.08 M | 100.00% | 0.90% | |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 483,836 | $1.04 M | 72.17% | 0.86% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 433,793 | $928,317 | -33.98% | 0.77% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 246,681 | $527,897 | -13.19% | 0.44% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 221,236 | $473,446 | 7.94% | 0.39% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 207,074 | $443,138 | 46.10% | 0.37% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 201,535 | $431,285 | 12.76% | 0.36% |
| FMR LLC | 02/13/2025 | 196,127 | $419,711 | 9.53% | 0.35% |
| STIFEL FINANCIAL CORP | 02/13/2025 | 166,000 | $355,240 | 10.43% | 0.29% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 165,678 | $354,551 | -24.58% | 0.29% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 144,600 | $309,444 | -3.08% | 0.26% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 140,000 | $299,600 | 12.00% | 0.25% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 131,874 | $282,210 | 122.81% | 0.23% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 109,224 | $233,739 | 0.00% | 0.19% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 107,275 | $229,569 | 100.00% | 0.19% |
| UBS OCONNOR LLC | 02/14/2025 | 104,560 | $223,758 | 15.27% | 0.19% |
| XTX TOPCO LTD | 02/13/2025 | 91,922 | $196,713 | 100.00% | 0.16% |
| BARCLAYS PLC | 02/13/2025 | 86,545 | $186,000 | 10.74% | 0.15% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 74,903 | $160,292 | 100.00% | 0.13% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 68,016 | $145,554 | 507.56% | 0.12% |
| RHUMBLINE ADVISERS | 01/30/2025 | 56,135 | $120,122 | 14.92% | 0.10% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 53,383 | $114,240 | 100.00% | 0.09% |
| UBS GROUP AG | 02/14/2025 | 49,893 | $106,771 | 29.74% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 34,672 | $74,198 | 100.00% | 0.06% |
| CITIGROUP INC | 02/12/2025 | 31,469 | $67,343 | 9.25% | 0.06% |
| FOUNDATIONS INVESTMENT ADVISORS, LLC | 01/22/2025 | 31,000 | $66,340 | -69.70% | 0.05% |
| 02/07/2025 | 31,000 | $66,340 | 100.00% | 0.05% | |
| LMR PARTNERS LLP | 02/14/2025 | 30,100 | $64,414 | -85.42% | 0.05% |
| HSBC HOLDINGS PLC | 02/14/2025 | 27,159 | $59,207 | 99.00% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 26,900 | $57,566 | -61.84% | 0.05% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 24,992 | $53,483 | 100.00% | 0.04% |
| POINT72 (DIFC) LTD | 02/14/2025 | 23,021 | $49,265 | 367.34% | 0.04% |
| SEI INVESTMENTS CO | 02/11/2025 | 22,802 | $48,796 | 100.00% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 22,766 | $48,719 | 11.95% | 0.04% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 22,388 | $47,910 | 0.00% | 0.04% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 21,640 | $46,310 | 0.00% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Black Diamond Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 119 institutional investors and hedge funds held shares of Black Diamond Therapeutics, Inc.. The most heavily invested institutionals were:
T. Rowe Price Investment Management, Inc.: 10.47 M
Bellevue Group AG: 8.52 M
Vestal Point Capital, LP: 5.6 M
NEA Management Company, LLC: 4.45 M
BlackRock Funding, Inc. /DE: 3.52 M
VANGUARD GROUP INC: 2.41 M
84.78% of Black Diamond Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 52.73 M shares in the last 24 months. This purchase volume represents approximately $112.32 M in transactions.